Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Short term Debt (2018 - 2025)

Ptc Therapeutics has reported Short term Debt over the past 11 years, most recently at $286.6 million for Q4 2025.

  • Quarterly results put Short term Debt at $286.6 million for Q4 2025, up 11.17% from a year ago — trailing twelve months through Dec 2025 was $286.6 million (up 11.17% YoY), and the annual figure for FY2025 was $286.6 million, up 11.17%.
  • Short term Debt for Q4 2025 was $286.6 million at Ptc Therapeutics, roughly flat from $286.3 million in the prior quarter.
  • Over the last five years, Short term Debt for PTCT hit a ceiling of $286.6 million in Q4 2025 and a floor of $33.1 million in Q1 2021.
  • Median Short term Debt over the past 5 years was $105.6 million (2023), compared with a mean of $153.4 million.
  • Biggest five-year swings in Short term Debt: surged 182.03% in 2021 and later rose 2.75% in 2025.
  • Ptc Therapeutics' Short term Debt stood at $59.3 million in 2021, then rose by 21.69% to $72.1 million in 2022, then soared by 169.32% to $194.3 million in 2023, then surged by 32.68% to $257.8 million in 2024, then grew by 11.17% to $286.6 million in 2025.
  • The last three reported values for Short term Debt were $286.6 million (Q4 2025), $286.3 million (Q3 2025), and $262.0 million (Q2 2025) per Business Quant data.